van der Laken CJ - Search Results

1

Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial.

Hartman L, Rasch LA, Turk SA, Ter Wee MM, Kerstens PJSM, van der Laken CJ, Nurmohamed MT, van Schaardenburg D, van Tuyl LHD, Voskuyl AE, Boers M, Lems WF. Hartman L, et al. Among authors: van der laken cj. Rheumatology (Oxford). 2023 Jun 1;62(6):2098-2105. doi: 10.1093/rheumatology/keac582. Rheumatology (Oxford). 2023. PMID: 36205538 Free PMC article. Clinical Trial.

2

Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis.

van der Laken CJ, Voskuyl AE, Roos JC, Stigter van Walsum M, de Groot ER, Wolbink G, Dijkmans BA, Aarden LA. van der Laken CJ, et al. Ann Rheum Dis. 2007 Feb;66(2):253-6. doi: 10.1136/ard.2006.057406. Epub 2006 Jun 22. Ann Rheum Dis. 2007. PMID: 16793840 Free PMC article.

3

2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis.

Elzinga EH, van der Laken CJ, Comans EF, Lammertsma AA, Dijkmans BA, Voskuyl AE. Elzinga EH, et al. Among authors: van der laken cj. Mol Imaging Biol. 2007 Nov-Dec;9(6):357-60. doi: 10.1007/s11307-007-0113-4. Mol Imaging Biol. 2007. PMID: 17902022 Free PMC article.

4

[The formation of infliximab and anti-infliximab immune complexes as an explanation for non-responding to infliximab treatment of rheumatoid arthritis: observational study in 4 patients].

van der Laken CJ, Voskuyl AE, Roos JC, Stigter van Walsum M, de Groot ER, Wolbink GJ, Dijkmans BA, Aarden LA. van der Laken CJ, et al. Ned Tijdschr Geneeskd. 2008 Jul 26;152(30):1672-7. Ned Tijdschr Geneeskd. 2008. PMID: 18714521 Dutch.

5

Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography.

van der Laken CJ, Elzinga EH, Kropholler MA, Molthoff CF, van der Heijden JW, Maruyama K, Boellaard R, Dijkmans BA, Lammertsma AA, Voskuyl AE. van der Laken CJ, et al. Among authors: van der heijden jw. Arthritis Rheum. 2008 Nov;58(11):3350-5. doi: 10.1002/art.23955. Arthritis Rheum. 2008. PMID: 18975347 Free article.

6

Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis.

Kropholler MA, Boellaard R, Elzinga EH, van der Laken CJ, Maruyama K, Kloet RW, Voskuyl AE, Dijkmans BA, Lammertsma AA. Kropholler MA, et al. Among authors: van der laken cj. Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):624-31. doi: 10.1007/s00259-008-0987-7. Epub 2008 Nov 29. Eur J Nucl Med Mol Imaging. 2009. PMID: 19043704

7

Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.

van der Heijden JW, Oerlemans R, Dijkmans BA, Qi H, van der Laken CJ, Lems WF, Jackman AL, Kraan MC, Tak PP, Ratnam M, Jansen G. van der Heijden JW, et al. Among authors: van der laken cj. Arthritis Rheum. 2009 Jan;60(1):12-21. doi: 10.1002/art.24219. Arthritis Rheum. 2009. PMID: 19116913 Free article.

8

Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.

van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, Scheffer GL, van der Laken CJ, Lems WF, Scheper RJ, Dijkmans BA, Jansen G. van der Heijden JW, et al. Among authors: van der laken cj. Arthritis Rheum. 2009 Mar;60(3):669-77. doi: 10.1002/art.24354. Arthritis Rheum. 2009. PMID: 19248091 Free article.

9

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.

Bos WH, Wolbink GJ, Boers M, Tijhuis GJ, de Vries N, van der Horst-Bruinsma IE, Tak PP, van de Stadt RJ, van der Laken CJ, Dijkmans BA, van Schaardenburg D. Bos WH, et al. Among authors: van der horst bruinsma ie, van der laken cj, van schaardenburg d, van de stadt rj. Ann Rheum Dis. 2010 Mar;69(3):490-4. doi: 10.1136/ard.2008.105759. Epub 2009 Apr 9. Ann Rheum Dis. 2010. PMID: 19363023

10

18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study.

Elzinga EH, van der Laken CJ, Comans EF, Boellaard R, Hoekstra OS, Dijkmans BA, Lammertsma AA, Voskuyl AE. Elzinga EH, et al. Among authors: van der laken cj. J Nucl Med. 2011 Jan;52(1):77-80. doi: 10.2967/jnumed.110.076711. Epub 2010 Dec 13. J Nucl Med. 2011. PMID: 21149486 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page